2nd Jan 2008 16:30
2 January 2008
Total Voting Rights
In accordance with DTR 5.6.1 of the FSA's Disclosure and Transparency Rules, Shire plc notifies the market of the following:
At close of business on 31 December 2007, Shire plc's issued voting share capital consisted of 556,945,587 Ordinary shares with a nominal value of 5 pence each and 731,302 special voting shares of 0.0001 pence each. Each ordinary share carries one voting right and each special voting share carries three voting rights. Shire plc does not hold any shares in Treasury.
Therefore the total number of voting rights in Shire plc is 559,139,493.
The above figure (559,139,493) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Shire plc under the FSA's Disclosure and Transparency Rules.
T MayCompany Secretary
For further information please contact:
Investor Relations Clĩa Rosenfeld (Rest of the World) +44 1256 894 160 Eric Rojas (North America) +1 484 595 8252 Notes to editorsSHIRE PLC
Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.
For further information on Shire, please visit the Company's website: www.shire.com.
Hampshire International Business Park Chineham Basingstoke Hampshire RG24 8EP United Kingdom Tel +44 (0)1256 894000 Fax +44 (0)1256 894708 www.shire.com Press Release
Registered in England 5492592Registered Office as above
SHIRE PLCRelated Shares:
Shire